No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Express News | Revvity Inc : Jefferies Cuts Target Price to $120 From $125
UBS Says 'Underweight the Names With High China Exposure'
China Neurogenomics Market Research 2024-2031, Profiles of Illumina, Thermo Fisher Scientific, F. Hoffmann-La Roche, MGI Tech, Agilent, Revvity, Qiagen, Pacific Biosciences, Danaher, Oxford Nanopore - ResearchAndMarkets.com
Does Revvity (NYSE:RVTY) Have A Healthy Balance Sheet?
Citi Maintains Revvity(RVTY.US) With Buy Rating, Maintains Target Price $145
Revvity's Strategic Market Position and Anticipated Growth Drive Buy Rating